The Prevalence of Coagulopathy and Associated Factors Among Adult Type II Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

被引:2
作者
Getu, Fasil [1 ]
Aynalem, Melak [2 ]
Bizuneh, Segenet [3 ]
Enawgaw, Bamlaku [2 ]
机构
[1] Jigjiga Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, POB 1020, Jigjiga, Ethiopia
[2] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia
[3] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Internal Med, Gondar, Ethiopia
来源
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2022年 / 15卷
关键词
coagulopathy; mixing study; type II diabetes mellitus; Gondar; Ethiopia; PARTIAL THROMBOPLASTIN TIME; LABORATORY IDENTIFICATION; COAGULATION ACTIVATION; FACTOR INHIBITORS; OBESITY;
D O I
10.2147/DMSO.S349412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Diabetes mellitus is a heterogeneous disorder of metabolism which results hyperglycemic-related atherothrombotic complications. These complications are the leading cause of death in diabetes mellitus patients. Therefore, this study was aimed to determine the prevalence of coagulopathy and associated factors among adult type II diabetes mellitus patients attending at University of Gondar comprehensive specialized hospital. Methods: A facility-based cross-sectional study was conducted among 357 study participants. A questionnaire and a data collection sheet were used to collect the sociodemographic and clinical data, respectively. About 6mL of venous blood samples were collected for coagulation tests and complete blood count. For prolonged coagulation tests, a mixing test was performed. Data were entered into EpiInfo and exported to SPSS for statistical analysis. Then, descriptive statistics were done. A binary and multivariable logistic regression model was used to identify the associated factors. P-value <0.05 was considered as statistically significant. Results: In this study, 357 study participants were included. Of them, 52.1% (186) and 80.7% (288) were females and urban residences, respectively. The prevalence of coagulopathy was 26.6% (95% CI: 22.1, 31.5%). Out of this, 12.3% and 8.7% showed shortened PT and aPTT, respectively. In addition, the prevalence of prolonged PT and aPTT were 5.6% and 3.9%, respectively. From the prolonged PT and aPTT, the prevalence of factor deficiency was 95% and 92.8%, respectively. Being female (AOR = 2.06; 95% CI: 1.11-3.85%), abnormal BMI (AOR = 1.94; 95% CI: 1.08-3.50), and educational status of high school (AOR = 0.26; 95% CI: 0.10-0.83%) were significantly associated with hypercoagulation. Conclusion: Coagulopathy is an important public health problem among type II diabetes mellitus patients. Being female and having abnormal BMI were associated with hypercoagulation. Therefore, regular monitoring of coagulation parameters is vital to reduce the consequence of coagulopathy.
引用
收藏
页码:579 / 590
页数:12
相关论文
共 57 条
  • [21] Ifeanyi OE, 2014, WORLD J PHARMA PHARM, V3, P52
  • [22] Ignjatovic Vera, 2013, Methods Mol Biol, V992, P121, DOI 10.1007/978-1-62703-339-8_9
  • [23] Ignjatovic Vera, 2013, Methods Mol Biol, V992, P111, DOI 10.1007/978-1-62703-339-8_8
  • [24] Ilyas S, 2013, J PUBLIC HLTH BIOL S, V2, P308
  • [25] International Diabetes Federation,, 2019, IDF DIABETES ATLAS, P36
  • [26] International Diabetes Federation, 2020, IDF AFR MEMB
  • [27] Karim F., 2015, J BANGLADESH SOC PHY, V10, P26, DOI DOI 10.3329/JBSP.V10I1.24614
  • [28] Mixing Tests: Diagnostic Aides in the Investigation of Prolonged Prothrombin Times and Activated Partial Thromboplastin Times
    Kershaw, Geoffrey
    Orellana, Daniel
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (03) : 283 - 290
  • [29] Laboratory identification of factor inhibitors: an update
    Kershaw, Geoffrey
    Favaloro, Emmanuel J.
    [J]. PATHOLOGY, 2012, 44 (04) : 293 - 302
  • [30] Laboratory Identification of Factor Inhibitors: The Perspective of a Large Tertiary Hemophilia Center
    Kershaw, Geoffrey
    Jayakodi, Dayani
    Dunkley, Scott
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (08) : 760 - 768